(Washington, D.C.) — A new academic analysis, “Independent Pharmacies in the U.S. are More on the Rise than on the Decline,” sets the record straight on the health of independent pharmacies in the U.S. by showing the overall number of
(Washington, D.C.) — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug prices, the Pharmaceutical Care Management Association (PCMA) is confirming its principles on transparency in the prescription drug supply chain. PCMA
Pennsylvania State Facts & Resources PBM Savings and Patient Impact in Pennsylvania Pharmacy benefit experts secure lower prescription drug costs and enable better health outcomes for patients. PBMs will save Pennsylvanians $45B across all Pennsylvania insurance markets over ten years
(Washington, D.C.) — The number of independent pharmacies in the United States increased in 2020, according to a new analysis of pharmacy data. Pharmacy data from the National Council for Prescription Drug Programs, analyzed by the healthcare analytics firm Quest
Lawmakers, health care experts, and drug pricing advocates agree that big drug companies block competition, are responsible for setting and increasing prices, and must be held accountable to end common and egregious patent abuse practices. These harmful anti-competitive practices keep
In case you missed it, business groups and individual employers from across the country signed the below letter to Congress expressing support for preserving their contracting flexibility and the protections provided by the Employee Income Security Act, ERISA. We appreciate
In case you missed it, Johnny Garcia, PharmD, Senior Director, Policy at the Pharmaceutical Care Management Association (PCMA), explains the critical role pharmacy benefit companies play in supporting all members of the prescription drug supply chain, including retail pharmacies, in
May is Asthma Awareness Month, and today – May 5 – is World Asthma Day. The Asthma and Allergy Foundation of America is marking the day with the release of their 2021 Asthma Capitals Report.
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting
©2024 PCMA. All Rights Reserved.
